|
| 37995859 | Engineering therapeutic monoclonal antibodies. | J Allergy Clin Immunol | 2024 |
| 36321821 | Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: AÂ systematic review and meta-analysis. | Allergy | 2023 |
| 37557950 | Drug allergy in older adults: A study from the United States Drug Allergy Registry. | Ann Allergy Asthma Immunol | 2023 |
| 37652140 | United States Drug Allergy Registry (USDAR) grading scale for immediate drug reactions. | J Allergy Clin Immunol | 2023 |
| 37459086 | Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial. | JAMA Intern Med | 2023 |
| 37182566 | Identifying and Managing Those at Risk for Vaccine-Related Allergy and Anaphylaxis. | J Allergy Clin Immunol Pract | 2023 |
| 37080457 | Active surveillance of alpha-gal (galactose-alpha-1,3-galactose) syndrome in Middle Tennessee. | Ann Allergy Asthma Immunol | 2023 |
| 37468039 | Quantification of peanut allergens across recalled and nonrecalled lots of diagnostic peanut extracts. | J Allergy Clin Immunol Pract | 2023 |
| 37295474 | Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach. | J Allergy Clin Immunol | 2023 |
| 36995329 | Clinical Presentation of Alpha-Gal Syndrome in Pediatric Gastroenterology and Response to Mammalian Dietary Elimination. | Am J Gastroenterol | 2023 |
| 36682226 | Perioperative implications of patients with alpha gal allergies. | J Clin Anesth | 2023 |
| 36108922 | Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis. | J Allergy Clin Immunol Pract | 2023 |
| 36100133 | Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit. | J Allergy Clin Immunol Pract | 2023 |
| 36089078 | Management of patients with immediate reactions to COVID-19 vaccines. | J Allergy Clin Immunol | 2023 |
| 34678498 | mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to pegaspargase. | J Allergy Clin Immunol Pract | 2022 |
| 35353440 | Oncologist counseling practice and COVID-19 vaccination outcomes for patients with history of PEG-asparaginase hypersensitivity. | Pediatr Blood Cancer | 2022 |
| 35678128 | Feasibility of a Centralized, Pharmacy-Led Penicillin Allergy Delabeling Program. | Hosp Pediatr | 2022 |
| 35765165 | Safety and value of pretransplant antibiotic allergy delabeling in a quaternary transplant center. | Transpl Infect Dis | 2022 |
| 35469619 | Hypersensitivity Reactions and Immune-Related Adverse Events to Immune Checkpoint Inhibitors: Approaches, Mechanisms, and Models. | Immunol Allergy Clin North Am | 2022 |
| 35469617 | Anaphylaxis to Excipients in Current Clinical Practice: Evaluation and Management. | Immunol Allergy Clin North Am | 2022 |
| 35398412 | Rapid progress in our understanding of COVID-19 vaccine allergy: AÂ cause for optimism, not hesitancy. | J Allergy Clin Immunol | 2022 |
| 35717132 | Allergy evaluation of messenger RNA vaccine reactions is crucial, with a specific role for polyethylene glycol testing. | Ann Allergy Asthma Immunol | 2022 |
| 35690369 | Retrospective stratification of cephalosporin allergy label risk using validated penicillin allergy frameworks. | J Allergy Clin Immunol Pract | 2022 |
| 36496214 | Bringing Data to Bear on the Mushy Middle: Riskier Immediate Reactions to Penicillin. | J Allergy Clin Immunol Pract | 2022 |
| 35940831 | Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol. | BMJ Open | 2022 |
| 35870755 | Reactivity to heparin in patients with alpha-gal allergy: A potential role for skin testing? | Ann Allergy Asthma Immunol | 2022 |
| 36036421 | Advances in immunoglobulin E mediated antibiotic allergy. | Curr Opin Pediatr | 2022 |
| 35131513 | Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting. | J Allergy Clin Immunol Pract | 2022 |
| 35188528 | Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis. | JAMA Intern Med | 2022 |
| 34979336 | Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy. | J Allergy Clin Immunol Pract | 2022 |
| 35297482 | Correction to: Dose, Timing, and Spectrum of Prenatal Antibiotic Exposure and Risk of Childhood Asthma. | Clin Infect Dis | 2022 |
| 34669610 | Understanding Penicillin Allergy, Cross-reactivity, and Antibiotic Selection in the Preoperative Setting. | J Am Acad Orthop Surg | 2022 |
| 32980582 | Criteria for intradermal skin testing and oral challenge in patients labeled as fluoroquinolone allergic. | J Allergy Clin Immunol Pract | 2021 |
| 33849961 | Breaking the Mold: Safely Delabeling Penicillin Allergies in Hospitalized Children. | Hosp Pediatr | 2021 |
| 33712848 | DDIWAS: High-throughput electronic health record-based screening of drug-drug interactions. | J Am Med Inform Assoc | 2021 |
| 33737254 | Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions. | J Allergy Clin Immunol Pract | 2021 |
| 34627544 | Reply to ''The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy". | J Allergy Clin Immunol Pract | 2021 |
| 34128562 | COVID-19 vaccine anaphylaxis: PEG or not? | Allergy | 2021 |
| 34293499 | An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history. | J Allergy Clin Immunol Pract | 2021 |
| 34061827 | High-throughput framework for genetic analyses of adverse drug reactions using electronic health records. | PLoS Genet | 2021 |
| 34033979 | Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System. | J Allergy Clin Immunol Pract | 2021 |
| 34028041 | Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose! | Allergy | 2021 |
| 34309623 | Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose. | JAMA Intern Med | 2021 |
| 31994697 | Dose, Timing, and Spectrum of Prenatal Antibiotic Exposure and Risk of Childhood Asthma. | Clin Infect Dis | 2021 |
| 33217616 | Anti-PEG IgE in anaphylaxis associated with polyethylene glycol. | J Allergy Clin Immunol Pract | 2021 |
| 32966878 | Safety, Efficacy, and Effectiveness of Delabeling in Patients with Multiple Drug Allergy Labels. | J Allergy Clin Immunol Pract | 2021 |
| 32822918 | Testing Strategies and Predictors for Evaluating Immediate and Delayed Reactions to Cephalosporins. | J Allergy Clin Immunol Pract | 2021 |
| 32992044 | Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS). | J Allergy Clin Immunol Pract | 2021 |
| 31049971 | The challenge of de-labeling penicillin allergy. | Allergy | 2020 |
| 31846796 | Tolerance of porcine pancreatic enzymes despite positive skin testing in alpha-gal allergy. | J Allergy Clin Immunol Pract | 2020 |